BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 74096)

  • 21. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
    Schröder M; von Heyden HW; Beyer JH; Klee M
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
    von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
    Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemotherapy of head and neck cancer.
    Carter SK
    Semin Oncol; 1977 Dec; 4(4):413-24. PubMed ID: 74095
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.
    Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH
    Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for head and neck tumours. Observations on a twelve-month study.
    Grant HR
    J Laryngol Otol; 1976 May; 90(5):433-40. PubMed ID: 58050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.
    Braakhuis BJ; Schoevers EJ; Heinerman EC; Sneeuwloper G; Snow GB
    Br J Cancer; 1983 Nov; 48(5):711-6. PubMed ID: 6196043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy in recurrent heat and neck cancer.
    Simmonds WP
    Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
    [No Abstract]   [Full Text] [Related]  

  • 29. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
    Yagoda A
    Cancer Res; 1977 Aug; 37(8 Pt 2):2775-80. PubMed ID: 68814
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early results of intraarterial application of bleomycin, methotrexate and proresid in locally advanced head and neck tumors.
    Auersperg M; Us-Krasovec M; Erjavec M; Plesnicar S
    Acta Med Iugosl; 1974; 28(5):421-9. PubMed ID: 4141218
    [No Abstract]   [Full Text] [Related]  

  • 33. Loco-regional localization pattern of head and neck tumors treated with general chemotherapy (methotrexate and bleomycin).
    Calciati A; Bumma C; La Grotta G; Gino GC; Falda M
    Panminerva Med; 1976; 18(5-6):177-9. PubMed ID: 57586
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiotherapy and chemotherapy in treatment of head and neck cancer.
    Dalley VM
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):173-9. PubMed ID: 75876
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
    Campbell JB; Dorman EB; McCormick M; Miles J; Morton RP; Rugman F; Stell PM; Stoney PJ; Vaughan ED; Wilson JA
    Acta Otolaryngol; 1987; 103(5-6):519-28. PubMed ID: 3303823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathohistologic changes after induction cytostatic therapy with methotrexate (M), bleomycin (B) and cisplatin (P)--(MBP)].
    Böheim K; Mikuz G; Böheim C
    Laryngol Rhinol Otol (Stuttg); 1982 May; 61(5):246-50. PubMed ID: 6178922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy of advanced head and neck tumors. Experience with various therapeutic schemes].
    Mañós M; Pericot J; Riu R; Gómez P; Villar A
    An Otorrinolaringol Ibero Am; 1983; 10(4):353-67. PubMed ID: 6194708
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
    Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new method of intraarterial chemotherapy of malignant head and neck tumors - first results (author's transl)].
    von Scheel J; Kastenbauer ER
    Laryngol Rhinol Otol (Stuttg); 1982 May; 61(5):238-41. PubMed ID: 6178921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.